Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Lupin launches Divalproex Sodium ER Tablets USP

Tue Sep 22 , 2020
Pharma major Lupin announced the launch of Divalproex Sodium Extended-Release (ER) Tablets USP, 250 mg and 500 mg, having received an approval from the United States Food and Drug Administration (USFDA) earlier. The product will be manufactured at Lupin’s Nagpur facility in India. Lupin Ltd is currently trading at Rs1,035.85, […]

Breaking News

Recent Posts